3
项与 MG-ZG122人源化单抗 相关的临床试验Safety, Tolerability, and Pharmacokinetics of MG-ZG122 in a Single Subcutaneous Injection in Chinese Healthy Adult Subjects: a Single-center, Randomized, Double-blind, Placebo-controlled, Dose-increasing Phase I Clinical Trial
To determine the safety and tolerability of MG-ZG122 in Chinese healthy adult subjects
MG-ZG122人源化单抗注射液在中国健康成年志愿者中单次皮下注射给药的安全性、耐受性、药代动力学研究:一项单中心、随机、双盲、安慰剂对照、剂量递增的Ⅰ期临床研究
确定MG-ZG122人源化单抗注射液在中国健康成年志愿者中的安全性、耐受性
Safety, tolerability, and pharmacokinetic profiles of MG-ZG122 humanized monoclonal antibody injection administered as a single subcutaneous injection in healthy Chinese adult volunteers: a single-center, randomized, double-blind, placebo-controlled, dose-escalating phase I clinical study
100 项与 MG-ZG122人源化单抗 相关的临床结果
100 项与 MG-ZG122人源化单抗 相关的转化医学
100 项与 MG-ZG122人源化单抗 相关的专利(医药)
100 项与 MG-ZG122人源化单抗 相关的药物交易